Author's Response to Letter to the Editor Regarding “Efficacy and Safety of Once‐Daily Prolonged‐Release Pregabalin for the Treatment of Patients With Diabetic Peripheral Neuropathy: A Randomized, Double‐Blind, Active, and Placebo‐Controlled Trial”